Cytosar Solution 100 mg/5 ml
Cytosar Solution 100 mg/5 ml is a medicine authorised by Swissmedic under authorisation number 54845. The authorisation holder is Pfizer AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 15 December 1999 and the authorisation is valid without a time limit. ATC code L01BC01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 54845 |
|---|---|
| Name | Cytosar Solution 100 mg/5 ml |
| Full name | Cytosar Solution 100 mg/5 ml, Injektionslöung |
| Authorisation holder | Pfizer AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BC01 |
| First authorisation | 15 December 1999 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Cytosar Solution 100 mg/5 ml, Injektionslöung | A | 15 December 1999 |
| 4 | Cytosar Solution 2 g/20 ml, Injektionslöung | A | 15 December 1999 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 14 | 1 | Durchstechflasche(n) | L01BC01 | 07.16.1. | A |
| 49 | 1 | Durchstechflasche(n) | L01BC01 | 07.16.1. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Cytosar Solution 100 mg/5 ml authorised in Switzerland?
Yes. Cytosar Solution 100 mg/5 ml is authorised by Swissmedic under authorisation number 54845, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Cytosar Solution 100 mg/5 ml have?
Cytosar Solution 100 mg/5 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Cytosar Solution 100 mg/5 ml?
The authorisation holder is Pfizer AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.